Home

Venrock Healthcare Capital Partners III, 10% Owner: KalVista Pharmaceuticals KALV Buy · Filed 24/01/29

Trade details

Type
Insider buy
Amount
$1,146,132
Shares · price
80,600 sh · $14.22 a share
Held after
4,650,584 sh
Trade date
24/01/29
Filed
24/01/29
Days to filing
0 days

First buy since 2023

Insiders buying this week
7 insiders
Holding change
+1.8%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/30~24/02/28

Venrock Healthcare Capital Partners III's recent trades